27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
- Moderna Inc (NASDAQ: MRNA) has agreed to supply the Philippines government with 13 million doses of its COVID-19 vaccine.
- Deliveries are set to begin in mid-2021.
- The company's COVID-19 vaccine is not currently approved for use in the country, and it will work with regulators to pursue necessary approvals before distribution.
- The company also anticipates a separate deal with the Philippines government and private sector to supply an additional 7 million doses.
- The Philippines regulator has so far approved for emergency use COVID-19 vaccines developed by Pfizer Inc (NYSE: PFE)/BioNTech SE (NASDAQ: BNTX), AstraZeneca Plc (NASDAQ: AZN), and Sinovac Biotech (NASDAQ: SVA).
- Price Action: MRNA shares are down 2.4% at $129.01 in premarket trading on the last check Monday.
27% profit every 20 days?
This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!